Teva Pharmaceutical Industries ADR

Teva Pharmaceutical Industries Ltd is a pharmaceutical company that operates internationally. The company develops, produces, and markets generic drugs, specialty pharmaceuticals, and active pharmaceutical ingredients. Founded in 1901, Teva has its headquarters in Tel Aviv-Yafo, Israel. Teva operates its business through three segments: North America, Europe, and International Markets. Through each business segment, the company handles the entire product portfolio for the given region, including over the counter (OTC), generic, and specialty products. The company offers sterile products, high-potency drugs, hormones, and cytotoxic substances in various dosage forms, including tablets, capsules, inhalants, injectables, creams, ointments, and liquids. The company also sells active pharmaceutical ingredients (API) to third parties, in addition to providing contract manufacturing services. Through its affiliate Medis, Teva offers a portfolio of products to other pharmaceutical companies. Teva stock is listed on the NYSE under the ticker TEVA. As of December 2021, the company maintains a portfolio of around 3,500 products. On a daily basis, approximately 200 million people across 60 countries benefit from one of Teva's medicines. The company's products focus on the central nervous system, respiratory, pain, and oncology areas. Learn more about TEVA share price values and the latest company news by adding it to your eToro watchlist.